Acne drug developer Dermira bumps up IPO to $98 million
September 19, 2014 at 23:04 PM EDT
Acne drug developer Dermira Inc. priced its initial public offering at up to $16 per share, bumping up its IPO by 31 percent since the Redwood City company initially disclosed the IPO in late August...